{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:42:43Z","timestamp":1790214163759,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00404-012-2456-6","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T09:35:23Z","timestamp":1343208923000},"page":"1537-1543","source":"Crossref","is-referenced-by-count":102,"title":["Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion"],"prefix":"10.1007","volume":"286","author":[{"given":"Xiaoxia","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bujian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"2456_CR1","first-page":"268","volume":"31","author":"F Zagouri","year":"2010","unstructured":"Zagouri F, Dimopoulos MA, Bournakis E, Papadimitriou CA (2010) Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy. Eur J Gynaecol Oncol 31:268\u2013277","journal-title":"Eur J Gynaecol Oncol"},{"key":"2456_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52\u201367","journal-title":"Cell"},{"key":"2456_CR3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000101310","volume":"185","author":"M Stallings-Mann","year":"2007","unstructured":"Stallings-Mann M, Radisky D (2007) Matrix metalloproteinase-induced malignancy in mammary epithelial cells. Cells Tissues Organs 185:104\u2013110","journal-title":"Cells Tissues Organs"},{"key":"2456_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10408360801973244","volume":"45","author":"W Cruz-Munoz","year":"2008","unstructured":"Cruz-Munoz W, Khokha R (2008) The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci 45:291\u2013338","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2456_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.10329","volume":"99","author":"P Vihinen","year":"2002","unstructured":"Vihinen P, Kahari VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99:157\u2013166","journal-title":"Int J Cancer"},{"key":"2456_CR6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1525-1438.2006.00448.x","volume":"16","author":"M Rauvala","year":"2006","unstructured":"Rauvala M, Aglund K, Puistola U, Turpeenniemi-Hujanen T, Horvath G, Will\u00e9n R, Stendahl U (2006) Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression. Int J Gynecol Cancer 16:1297\u20131302","journal-title":"Int J Gynecol Cancer"},{"key":"2456_CR7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1525-1438.2006.00717.x","volume":"16","author":"O Graesslin","year":"2006","unstructured":"Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Dara\u00ef E (2006) Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 16:1911\u20131917","journal-title":"Int J Gynecol Cancer"},{"key":"2456_CR8","first-page":"1417","volume":"24","author":"S Ozalp","year":"2003","unstructured":"Ozalp S, Tanir HM, Yalcin OT, Kabukcuoglu S, Oner U, Uray M (2003) Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors. Eur J Gynaecol Oncol 24:1417\u20131420","journal-title":"Eur J Gynaecol Oncol"},{"key":"2456_CR9","first-page":"2396","volume":"7","author":"B Schmalfeldt","year":"2001","unstructured":"Schmalfeldt B, Prechtel D, Harting K et al (2001) Increased expression of matrix metalloproteinases (MMP)-2, MMP-9 and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7:2396\u20132404","journal-title":"Clin Cancer Res"},{"key":"2456_CR10","first-page":"1239","volume":"33","author":"JL Brun","year":"2008","unstructured":"Brun JL, Cortez A, Commo F, Uzan S, Uzan S, Rouzier R, Dara\u00ef E (2008) Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Int J Oncol 33:1239\u20131246","journal-title":"Int J Oncol"},{"key":"2456_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/153537020623100103","volume":"231","author":"M Ii","year":"2006","unstructured":"Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231:20\u201327","journal-title":"Exp Biol Med (Maywood)"},{"key":"2456_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13277-010-0020-1","volume":"31","author":"S Koskensalo","year":"2010","unstructured":"Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstr\u00f6m J, Haglund C (2010) MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol 31:149\u2013155","journal-title":"Tumour Biol"},{"key":"2456_CR13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/ijc.21989","volume":"119","author":"SB Somiari","year":"2006","unstructured":"Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD (2006) Circulating MMP2 and MMP9 in breast cancer potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119:1403\u20131411","journal-title":"Int J Cancer"},{"key":"2456_CR14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6603958","volume":"97","author":"NG Hurst","year":"2007","unstructured":"Hurst NG, Stocken DD, Wilson S, Keh C, Wakelam MJ, Ismail T (2007) Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients. Br J Cancer 97:971\u2013977","journal-title":"Br J Cancer"},{"key":"2456_CR15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/ijc.23337","volume":"122","author":"ZS Wu","year":"2008","unstructured":"Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, Xu XC (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 122:2050\u20132056","journal-title":"Int J Cancer"},{"key":"2456_CR16","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0959-8049(03)00427-1","volume":"39","author":"L Manenti","year":"2003","unstructured":"Manenti L, Paganoni P, Floriani I et al (2003) Expression levels of vascular endothelial growth factor, matrix metalloproteinases-2 and -9 and tissue inhibitor of metalloproteinases-1 and -2 in the plasma of patients with ovarian carcinoma. Eur J Cancer 39:1948\u20131956","journal-title":"Eur J Cancer"},{"key":"2456_CR17","first-page":"2753","volume":"27","author":"M M\u00e4\u00e4tta","year":"2007","unstructured":"M\u00e4\u00e4tta M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Santala M (2007) Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours. Anticancer Res 27:2753\u20132758","journal-title":"Anticancer Res"},{"key":"2456_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.2001.6243","volume":"82","author":"E Lengyel","year":"2001","unstructured":"Lengyel E, Schmalfeldt B, Konik E et al (2001) Expression of latent matrix metalloproteinase-9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol 82:291\u2013298","journal-title":"Gynecol Oncol"},{"key":"2456_CR19","first-page":"673","volume":"17","author":"K Sakata","year":"2000","unstructured":"Sakata K, Shigemasa K, Nagai N, Ohama K (2000) Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int J Oncol 17:673\u2013681","journal-title":"Int J Oncol"},{"key":"2456_CR20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","volume":"12","author":"AA Kamat","year":"2006","unstructured":"Kamat AA, Fletcher M, Gruman LM et al (2006) The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res 12:1707\u20131714","journal-title":"Clin Cancer Res"},{"key":"2456_CR21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10517-010-1010-4","volume":"149","author":"ES Gershtein","year":"2010","unstructured":"Gershtein ES, Levkina NV, Digayeva MA, Laktionov KP, Tereshkina IV, Kushlinsky NE (2010) Matrix metalloproteinases-2, -7, and -9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasms. Bull Exp Biol Med 149:628\u2013631","journal-title":"Bull Exp Biol Med"},{"key":"2456_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000110426","volume":"28","author":"S Sillanp\u00e4\u00e4","year":"2007","unstructured":"Sillanp\u00e4\u00e4 S, Anttila M, Suhonen K et al (2007) Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 in epithelial ovarian cancer. Tumour Biol 28:280\u2013289","journal-title":"Tumour Biol"},{"key":"2456_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ygyno.2006.09.004","volume":"104","author":"S Sillanp\u00e4\u00e4","year":"2007","unstructured":"Sillanp\u00e4\u00e4 S, Anttila M, Voutilainen K et al (2007) Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol 104:296\u2013303","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2456_CR24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3892\/or.2011.1608","volume":"27","author":"JL Brun","year":"2011","unstructured":"Brun JL, Cortez A, Lesieur B, Uzan S, Rouzier R, Dara\u00ef E (2011) Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer. Oncol Rep 27(4):1049\u20131057","journal-title":"Oncol Rep"},{"key":"2456_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.20697","volume":"114","author":"FQ Wang","year":"2005","unstructured":"Wang FQ, So J, Reierstad S, Fishman DA (2005) Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114:19\u201331","journal-title":"Int J Cancer"},{"key":"2456_CR26","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.22067","volume":"119","author":"SM Sillanp\u00e4\u00e4","year":"2006","unstructured":"Sillanp\u00e4\u00e4 SM, Anttila MA, Voutilainen KA, Ropponen KM, Sironen RK, Saarikoski SV, Kosma VM (2006) Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression. Int J Cancer 119:1792\u20131799","journal-title":"Int J Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-012-2456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2456-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:11:34Z","timestamp":1562001094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-012-2456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s00404-012-2456-6","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}